Stanford University
Showing 31-40 of 732 Results
-
Julie Baker
Professor of Genetics
Current Research and Scholarly InterestsWe examine how cells communicate and function during fetal development. The work in my laboratory focuses on the establishment of specific cell fates using genomics to decipher interactions between chromatin and developmental signaling cascades, between genomes and rapidly evolving cell types, and between genomic copy number variation and gene expression. In recent years we have focused on the vastly understudied biology of the trophoblast lineage, particularly how this lineage evolved.
-
Laurence Baker
Professor of Health Policy, Senior Fellow at the Stanford Institute for Economic Policy Research and Professor, by courtesy, of Economics
Current Research and Scholarly InterestsDr. Baker's research is in the area of health economics, and focuses on the effects of financial incentives, organizational structures, and government policies on the health care delivery system, health care costs, and health outcomes.
-
Zhenan Bao
K. K. Lee Professor, Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Materials Science and Engineering, of Chemistry, and of Bioengineering
BioZhenan Bao joined Stanford University in 2004. She is currently a K.K. Lee Professor in Chemical Engineering, and with courtesy appointments in Chemistry, Bioengineering and Material Science and Engineering. She was the Department Chair of Chemical Engineering from 2018-2022 and in 2025. She founded the Stanford Wearable Electronics Initiative (eWEAR) and is the current faculty director. Bao received her Ph.D. degree in Chemistry from The University of Chicago in 1995 and joined Bell Labs, Lucent Technologies. She became a Distinguished Member of Technical Staff in 2001. Professor Bao currently has more than 800 refereed publications and more than 80 US patents with a Google Scholar H-index 237.
Bao is a member of the US National Academy of Sciences, National Academy of Engineering, the American Academy of Arts and Sciences and the National Academy of Inventors. Bao was elected a foreign member of the Chinese Academy of Science in 2021. She is a Fellow of AAAS, ACS, MRS, SPIE, ACS POLY and ACS PMSE.
Bao is a member of the Board of Directors for the Camille and Dreyfus Foundation from 2022. She served as a member of Executive Board of Directors for the Materials Research Society and Executive Committee Member for the Polymer Materials Science and Engineering division of the American Chemical Society. She co-founded C3 Nano Co. (acquired by Du Pont) and PyrAmes, which have produced products used in commercial smartphones and hospitals, respectively. Multiple inventions from her lab have been licensed and served as foundational technologies for several additional start-ups.
Bao was a recipient of the VinFuture Prize Female Innovator 2022, ACS Award of Chemistry of Materials 2022, MRS Mid-Career Award in 2021, AICHE Alpha Chi Sigma Award 2021, ACS Central Science Disruptor and Innovator Prize in 2020, ACS Gibbs Medal in 2020, the Wilhelm Exner Medal from the Austrian Federal Minister of Science in 2018, the L'Oreal UNESCO Women in Science Award North America Laureate in 2017. She was awarded the ACS Applied Polymer Science Award in 2017, ACS Creative Polymer Chemistry Award in 2013 ACS Cope Scholar Award in 2011. She is a recipient of the Royal Society of Chemistry Beilby Medal and Prize in 2009, IUPAC Creativity in Applied Polymer Science Prize in 2008.
In Stanford, Bao has pioneered molecular design concepts and fabrication processes to advance the scope and applications of skin-inspired electronics. Her group discovered nano confinement effect of conjugated polymers in polymer blends, which established the fundamental foundation for skin-inspired electronic materials and devices. Her work has resulted in new materials and device solutions for soft robotics, wearable and implantable electronics for precision health, precision mental health and advanced tools for understanding neuroscience and treatment of neurodegenerative diseases. Building on chemical insights, her group has developed foundational materials and devices that enabled a new generation of skin-inspired soft electronics. They provide unprecedented opportunities for understanding human health through developing monitoring, diagnosis and treatment tools. Some examples include: a neuromorphic e-skin that can sense force and temperature and directly communicate with brain, a wireless wound healing patch, a soft NeuroString for simultaneous neurochemical monitoring in the brain and gut, soft high-density electrophysiological recording array, a meta-learned skin sensor for detailed body movements, a reconfigurable self-healing electronic skin. -
Tina Baykaner
Assistant Professor of Medicine (Cardiovascular Medicine)
BioTina Baykaner, MD, MPH is an Assistant Professor of Medicine in the Division of Cardiovascular Medicine and Cardiac Electrophysiology at Stanford University School of Medicine. She completed residency and fellowships in cardiovascular medicine and advanced heart failure at the University of California, San Diego, followed by fellowship training in cardiac electrophysiology at Stanford. She joined the Stanford faculty in 2018 and was promoted to Assistant Professor in 2023.
Dr. Baykaner’s research program focuses on atrial fibrillation (AF), cardio-oncology, and the integration of artificial intelligence and machine learning into cardiac electrophysiology. She is Principal Investigator of an NIH R01 investigating atrial fibrillation in patients with hematologic malignancies treated with tyrosine kinase inhibitors and previously led an NIH K23 award focused on personalizing AF management using machine learning. She also serves as co-investigator or consultant on multiple NIH-funded R01 projects in artificial intelligence, ventricular arrhythmias, and digital cardiovascular phenotyping. Her work spans AF mechanisms, ablation outcomes, digital health implementation, and equity in arrhythmia care.
She has authored over 200 peer-reviewed publications, book chapters, and abstracts, including more than 100 original research manuscripts, and has delivered over 100 invited lectures nationally and internationally. She served as a task force member for the 2024 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation and holds editorial leadership roles, including Associate Editor for the Journal of Interventional Cardiac Electrophysiology and editorial board positions with multiple electrophysiology journals.
Dr. Baykaner is Vice-Chair of the Heart Rhythm Society Digital Education Committee and serves on national program and grant review committees, including NIH/NHLBI study sections. She is actively engaged in mentorship across undergraduate, medical, graduate, and postdoctoral levels, with mentees who have received national awards and progressed to electrophysiology fellowship and faculty positions.
Her clinical practice focuses on catheter ablation of atrial and ventricular arrhythmias, supraventricular tachycardias, management of inappropriate sinus tachycardia, cardiac implantable electronic device implantation and extraction, and advanced rhythm management strategies in complex patient populations. -
Hans-Christoph Becker, MD, FSABI, FSCCT
Clinical Professor, Radiology
Current Research and Scholarly InterestsMyocardial bridges (MB) with associated upfront atherosclerotic lesions are common findings on coronary computed tomography angiography (CTA). Abnormal septal wall motion in exercise echocardiography (EE) may to be associated with MB. Intravascular ultrasound (IVUS) is considered the gold standard for the detection of MB. We investigate whether CTA is comparable to IVUS for the assessment of MB and upstream plaques in symptomatic patients with suspicion for MB raised by EE.
-
Gill Bejerano
Professor of Developmental Biology, of Computer Science and of Pediatrics (Genetics)
Current Research and Scholarly Interests1. Automating monogenic patient diagnosis.
2. The genomic signatures of independent divergent and convergent trait evolution in mammals.
3. The logic of human gene regulation.
4. The reasons for sequence ultraconservation.
5. Cryptogenomics to bridge medical silos.
6. Cryptogenetics to debate social injustice.
7. Managing patient risk using machine learning.
8. Understanding the flow of money in the US healthcare system.
